Response to Beretich and Beretich
Genet Med
.
2023 Oct;25(10):100903.
doi: 10.1016/j.gim.2023.100903.
Epub 2023 May 25.
Authors
Jerry Vockley
1
,
Nicola Brunetti-Pierri
2
,
Wendy K Chung
3
,
Angus J Clarke
4
,
Nina Gold
5
,
Robert C Green
6
,
Stephen Kagan
7
,
Tara Moroz
7
,
Christian P Schaaf
8
,
Martin Schulz
7
,
Elfride De Baere
9
Affiliations
1
University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA. Electronic address: gerard.vockley@chp.edu.
2
Department of Translational Medicine, Federico II University, Naples, Italy; Telethon Institute of Genetics and Medicine, Pozzuoli, Italy.
3
Division of Molecular Genetics, Departments of Pediatrics and Medicine, Columbia University, New York, NY.
4
Cancer & Genetics, School of Medicine, Cardiff University, Wales, United Kingdom.
5
Mass General Hospital for Children, Division of Medical Genetics and Metabolism and Harvard Medical School, Boston, MA.
6
MassGeneralBrigham, Ariadne Labs, Broad Institute and Harvard Medical School, Boston, MA.
7
Gene Therapy Platform and Cross Portfolio, Global Medical Affairs, Rare Disease, Pfizer Inc.
8
Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.
9
Center for Medical Genetics, Ghent University Hospital and Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
PMID:
37245089
DOI:
10.1016/j.gim.2023.100903
No abstract available
Publication types
Letter